CJC-1295 DAC Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: sustained growth hormone signaling

Growth Signal Research peptide Lyophilized verified

Also known as: CJC1295 DAC, CJC DAC

Open in Calculator ← Compound Index All Tools

Quick Facts

Reference Sizes

2 mg, 5 mg, 10 mg

Calculator

Preset available

Storage

Lyophilized: store at -20 deg C. After reconstitution: refrigerate 2-8 deg C; verify beyond-use timing against source COA.

Solubility

Clinical formulation was study-specific; retail lyophilized material has no approved universal reconstitution standard

Catalog Description

CJC-1295 DAC is a long-acting growth-hormone-releasing-hormone analog containing a drug-affinity-complex moiety that covalently binds albumin. Small healthy-adult studies used subcutaneous doses of 30-180 micrograms/kg and found sustained GH and IGF-1 changes. It is investigational and is not equivalent to products marketed as CJC-1295 No DAC.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life

Estimated 5.8-8.1 days in the healthy-adult study

Onset

GH increased within hours and remained elevated for six days or longer in the published study

Administration Routes (Research)

SC (published human study)

Reported Research Effects

GHRH-receptor agonism
Sustained GH elevation for at least six days in a small human study
IGF-1 elevation for approximately nine to eleven days

Reported Research Side Effects

Injection-site reactions
Flushing
Headache
FDA reports include increased heart rate and systemic vasodilatory reaction

Data source: Primary human PK and pharmacodynamic study, FDA safety review, and current vendor market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

30 or 60 ug/kg as a single dose [SC; Single-dose clinical cohort; Once]Source: healthy-adult study PMID 16352683

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Other growth-hormone secretagogues or exogenous growth hormone without monitored research oversight

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

Current RUO vendors commonly list 2 mg 5 mg and 10 mg vials. Published human evidence is limited to small early-phase studies and does not establish clinical efficacy.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

Prolonged stimulation of GH and IGF-I by CJC-1295 — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/16352683/

FDA list of bulk substances presenting potential safety risks — U.S. Food and Drug Administration
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Reconstitution CalculatorConcentration, draw volume, per-unit amounts Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.